Mike Harley Appointed Chief Franchisor Officer at Galt Phranchise Systems
Galt Phranchise Systems is proud to announce the appointment of Mike Harley as its new Chief Franchisor Officer.
'I am thrilled to join the Galt family and contribute to its mission of delivering accessible healthcare products through a robust franchise network.'— Mike Harley
ATLANTA, GA, UNITED STATES, May 20, 2025 / EINPresswire.com / -- Galt Phranchise Systems LLC (' GPS ') is proud to announce Mike Harley's appointment as its new Chief Franchisor Officer. Harley will bring decades of experience in franchise development and strategic business growth to the company.
With a career spanning over 40 years, Mike has built and led successful national and international franchise systems, transforming brands into global powerhouses. Mike's franchise expertise dates back to 1983, when he played a pivotal role in expanding a low-cost car rental brand into a global network of over 1,000 locations across 50 countries. Later, as President and COO of Payless Car Sales, he started and led the company's growth to nearly 60 dealerships across 16 states and Puerto Rico in under five years. His leadership propelled brands to new heights, earning them recognition on the Franchise Times Top 200 Franchises List.
Beyond franchising, Mike has guided strategic growth and development across multiple industries, including travel, parking, retail, e-commerce, digital marketing, and other B2C verticals. His ability to boost revenue, profitability, and operational efficiency has made him a sought-after visionary strategist for franchise brands looking to scale.
At GPS, Mike will spearhead Galt's franchise expansion efforts, ensuring that Galt Pharmaceuticals ' FDA-approved products reach a broader audience through a well-planned and sustainable growth model. His dynamic, hands-on leadership and forward-thinking vision will be instrumental in shaping GPS's future as the first-ever pharmaceutical franchise model.
'I am thrilled to join the Galt family and contribute to its mission of delivering accessible healthcare products through a robust franchise network,' said Harley. 'Franchising is a powerful tool for growth, and I look forward to leveraging my experience to support franchisees and elevate the brand's success.'
About Galt Phranchise Systems
Based in Atlanta, GA, Galt Phranchise Systems (GPS) is the first and only franchisor to partner with a pharmaceutical company to create a unique franchise concept that allows an entrepreneur or business entity to market and promote pharmaceutical and health-related products in their local markets. With Galt Pharmaceuticals ( www.galtrx.com ) managing the high-barrier industry functions, Galt Phranchise Systems has worked hard in building the foundation and business systems that allow Phranchise Owners to focus on operating their truly patient-centric, local businesses. With over 500 territories available across the nation, GPS seeks entrepreneurial-minded sales or healthcare professionals looking to disrupt the big pharma model by decentralizing pharmaceutical sales and distribution.
Tucker Bedingfield
Galt Companies
+1 855-965-2783
email us here
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Stadium bill, disaster aid sail through Missouri House committees
St. Louis Mayor Cara Spencer listens to a question Tuesday as she testifies on the need for tornado relief funds alongside city policy director Casey Millburg. (Rudi Keller/Missouri Independent) The special session bills to fund professional sports stadiums in Kansas City and provide disaster relief to St. Louis passed House committees easily on Tuesday, setting up final votes that will send them to Gov. Mike Kehoe. There were no changes from the Senate-approved versions as the stadium financing bill passed the House Economic Development Committee on an 11-2 vote and a spending bill with $100 million for storm cleanup in St. Louis by a unanimous vote. As long as there are no amendments passed on the floor, those two bills and another to authorize disaster housing support will be finished Wednesday. If there are any changes, they will have to be approved by the state Senate, which passed all three bills last week. The immediate purpose of the special session was to get state lawmakers on record with an offer to the NFL's Kansas City Chiefs and MLB's Royals before the teams had to make a decision on whether to jump the state line to take a deal offered by Kansas. The Kansas offer, with a deadline at the end of the month, is a serious proposal and Missouri will lose the teams — and the economic activity associated with them — if it does not put up a counter-offer, said state Sen. Kurtis Gregory, a Republican from Marshall. Under the stadium bill, Missouri would calculate the tax revenue generated by activities in Arrowhead and Kauffman stadiums — home of the Chiefs and Royals, respectively, since the early 1970s — and dedicate the money to bond payments. 'This isn't using tax dollars off of the income tax that's collected from someone that's working at Dollar General or a feed store or a fertilizer shop or a clothing store or wherever,' Gregory said. 'This is using the taxes that are generated at the stadiums themselves, off of Joe Burrow when he comes to play in Kansas City, we collect taxes off his paycheck, or when Taylor Swift has a concert at Arrowhead Stadium.' Backers of the bill estimate that close to $1.5 billion would be spent over 30 years. The money would pay about half the cost of upgrades at Arrowhead and a brand new stadium for the Royals. Opponents of the plan tried to persuade the committee to wait. The Chiefs and Royals have not accepted the Kansas offer and haven't promised to stay if Missouri makes a firm financial commitment, said Patrick Tuohey, a senior fellow at the conservative Show-Me Institute. 'This entire special session and this deal is an absolute hustle,' Tuohey said. The Kansas offer is dependent on investors being willing to buy bonds backed only by the new tax revenue generated in a district around the stadiums, Tuohey said. That won't be enough money to service the debt, he said. 'This deadline simply means that the Kansas offer ends,' Tuouhey said. 'The absolute worst time for Missouri to offer, to make an offer is during that time. You should wait until after the 30th and see if Kansas wants to extend. But the idea that the Chiefs and the Royals are dictating deadlines to the Missouri Legislature is crazy.' Under the legislation, Missouri would keep money received that exceeds the current tax revenue, Gregory said. And if the teams move, he added, the state loses both. 'We're not talking just about the potential revenue loss for the team moving across the state lines,' he said. 'I think we are talking about jobs and tax revenue coming from a lot of different places across the Kansas City metro area.' The property tax cap in the legislation would apply to 97 counties, 75 where base bills could not increase more than 5% per year and 22 more where no increase would be allowed. The bill exempts additions to the tax bill for newly voted levies and the additional value of home improvements. The bill includes two other major provisions, with the most expensive being a tax credit for people living in areas where a federal disaster declaration has been requested. The credit would be equal to their insurance deductible and available regardless of whether the disaster request is approved. The other provision would renew a tax credit program that supports major amateur sporting events. The disaster tax credit, only for damage occurring this year, would be capped at $5,000 per person and $90 million total this year. For people who cannot use their full tax credit, the bill would allow them to carry the loss forward for another 29 years and cap the total allowed at $45 million per year. The provision could eventually cost state taxpayers about $600 million, Dan Haug, state budget director, said in testimony to the House Budget Committee. 'That is what I would call an upper limit,' he said. In the spending bill, Kehoe initially sought $25 million for housing assistance grants, adding it to the core items he wanted from a construction bill spiked in the House just before a final vote in the regular session. Under pressure from Democratic lawmakers in the Senate — votes vital to passing the stadium package — Kehoe agreed to add $100 million to help St. Louis recover from a devastating tornado that hit May 16. The bill spends $360 million overall — $175 million of general revenue and $185 million from other funds. Despite grumbling that many items in the bill spiked during the regular session were badly needed, House Budget Committee Chairman Dirk Deaton, a Republican from Noel, said nothing would be added. When Kehoe agreed to the additional money, federal recovery aid for St. Louis was uncertain. That changed Monday when President Donald Trump approved the request for a disaster declaration, making federal help to the state and local governments available as well as aid to individuals with damaged property. The federal recovery aid is welcome but the state funding should be maintained, Haug said to the budget committee. 'These disasters are so expensive that without federal help, there's no way we can cover all of this,' Haug said. 'We just don't have the general revenue resources to do that.' Just in the city of St. Louis, Mayor Cara Spencer told the committee, the tornado damaged 23,000 homes and affected 48,000 people. 'Many of the homes that are so badly damaged are generational homes,' Spencer said. 'These are homes that represent all the most that many of these families have.' SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
New York Post
4 hours ago
- New York Post
Lab-grown salmon is now FDA approved — here's why this one restaurant is putting it on the menu
Land ho! You've heard of fresh-caught salmon and even farm-raised — but what about lab-grown? San Francisco cellular agriculture company Wildtype is the latest company to get FDA approval for its lab-grown salmon Only three other companies have gotten the stamp of approval to sell cultivated salmon so far. The company made waves in the food and culinary sectors after announcing that its hero product, saku salmon, got approved in 'a thorough pre-market safety consultation.' Curious people can find the fish on the menu at Portland, Oregon, restaurant Kann — a James Beard award-winning Haitian spot by chef Gregory Gourdet. For June, the cultured salmon will only grace the menu every Thursday night, but in July, it is slated to be a nightly offering. 'Our saku is sushi-grade and best served raw in dishes like sushi, crudo, and ceviche,' Wildtype explains on its website. 'We made it for world-class chefs who seek out the distinct flavor and freshness of raw seafood.' And according to the FDA, they view lab-grown salmon 'as safe as comparable foods produced by other methods,' the FDA wrote in its public response letter. The FDA's only gripe with Wildtype's cultivated salmon so far is that the company refers to it as 'cultured salmon cell material' — which is not 'our recommendation of that term as an appropriate common or usual name for declaring the substance in accordance with FDA's labeling requirements,' the agency said. This interest in lab-grown salmon is due to both wild-caught and farm-raised versions containing levels of mercury. Wild-caught salmon is also susceptible to picking up chemicals in local waters. So, how exactly is lab-grown salmon made? The process can be broken down into three steps: source, grow and harvest. Living cells from Pacific salmon are taken from fish and then placed into cell cultivators that mimic the temperature, pH, and nutrients of a wild fish — allowing the cells to grow, as explained by Wildtype. Once fully matured and harvested, the living 'salmon cells' are fused with plant-based ingredients that imitate the texture and appearance of true salmon. Experts warn that typically, both wild-caught and farm-raised salmon contain traceable levels of mercury and are susceptible to picking up chemicals in local waters. Oran Tantapakul – By producing synthetic seafood, Wildtype says it aims to 'sustainably meet the food security challenges of this century' and minimize the damaging environmental implications of farming and fishing practices, while reducing 'exposure to common contaminants we'd rather avoid.' According to the Washington State Department of Health, farmed salmon can sometimes be exposed to organic contaminants and pests like sea lice more often than wild-caught salmon, but rest assured: 'most of the salmon available for us to eat is farmed,' the agency says. Synthetic salmon hasn't hit the grocery store shelves just yet but given cultural interest in plant-based, meatless, and lab-grown products — that day seems to be just around the corner.
Yahoo
6 hours ago
- Yahoo
Opinion - Trump shouldn't import socialist price controls
Remember when Republican presidential candidate Donald Trump castigated 'Comrade Kamala' Harris, then the Democratic nominee, for supporting price controls? It wasn't that long ago — just last August. At a campaign rally in Pennsylvania, Trump told the crowd: 'In her speech yesterday, Kamala went full Communist … She wants to destroy our country. After causing catastrophic inflation, Comrade Kamala announced that she wants to institute socialist price controls.' Harris's price controls were largely aimed at food in grocery stores, though she also frequently touted the 2022 Inflation Reduction Act's backdoor price controls — under the guise of 'negotiations' — on a certain number of expensive drugs. Trump was right to criticize Harris for supporting price controls on food, as well as prescription drugs. And, given the election results, it seems the public agreed with him. Price controls are the progressive left's go-to solution for almost all economic problems. But price controls virtually always lead to unintended consequences: shortages of the price-controlled products or services; lower quality as manufacturers cut corners to meet government-imposed price points; less innovation, since companies don't know if they'll be allowed to recover their costs; and a black market where people pay more to get what they want or need. So it's puzzling to see Trump now proposing a version of drug price controls himself. It's not the first time, either. During his first term, Trump pushed for 'drug importation,' encouraging U.S. citizens to buy medicines from countries like Canada — even though the FDA has warned those drugs could be fake or substandard. The effort fizzled, and even Florida, which tried a state-level importation scheme, eventually abandoned its program. Trump's latest idea is called 'Most Favored Nation' pricing. Details are thin, but a recent executive order says, 'To the extent consistent with law, the Secretary of Health and Human Services (Secretary) shall facilitate direct-to-consumer purchasing programs for pharmaceutical manufacturers that sell their products to American patients at the most-favored-nation price.' That 'most-favored' country will almost certainly be one with government-run health care — that is, socialized medicine. These systems are known for price controls, which lead to shortages, long wait times, and limited access to cutting-edge treatments. The goal of Most Favored Nation is to lower prices on expensive drugs. Americans do pay more for brand-name drugs than patients elsewhere. But they also pay less for generics, which account for roughly 90 percent of all prescriptions. One reason for the disparity is the middlemen in our system, known as pharmacy benefit managers. Their job is to negotiate lower prices with drugmakers. But those savings often don't make it to patients. Instead, pharmacy benefit managers keep a big chunk for themselves — on average, $0.42 of every $1 spent on brand-name drugs in the commercial market, by one estimate. In many cases, those pharmacy benefit manager cuts are larger than the total price of the drug in Europe. It's clear our system could work better. 'Shark Tank' entrepreneur Mark Cuban launched the Cost Plus Drug Company in 2022 to bypass these middlemen. The Cost Plus website says, 'Our prices are the true cost to get each medication from the manufacturer to you. We cut out the pharmacy middlemen and negotiate directly with manufacturers to get the best possible price.' The company tacks on 15 percent for overhead and a $5 filling fee. While customers may not save much on some widely used generics, the discounted prices on more expensive brand name and generic drugs are significantly lower than what most people would experience at their local pharmacy. Cost Plus has hundreds of drugs for nearly 100 listed medical conditions, and it's looking to add new drugs all the time. It's only been in business a few years and is working to expand. We also shouldn't ignore the fact that Americans are subsidizing below-market prices abroad. The United States funds a disproportionate share of global pharmaceutical innovation, while other wealthy nations impose price caps and benefit from our investment. If Trump wants to stop other countries from taking advantage of us, he should take the approach he's using to get countries to pay more for defense. Cuban's Cost Plus experiment proves we don't need Most Favored Nation pricing. Let socialized systems keep their socialized prices, limited access and denial of care. Tweaking a line Trump likes to use and applying it to prescription drugs: We don't need a new law. We just don't need a middleman. Merrill Matthews is a public policy and political analyst and the co-author of 'On the Edge: America Faces the Entitlements Cliff.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
